Conventional radiological imaging fails to diagnose occult insulinoma and nesidioblastosis; hence, newer diagnostic tools like glucagon-like peptide 1 receptors, Ga-68 DOTANAC PET, and selective arterial calcium stimulation (SACS) have emerged [11]. This evidence concerns the gene GLP1R and pancreatic insulinoma.